It’s Not that Simple: Young Women and Melanoma

By Cody R. Barnett, MRA Director of Communications | 15 February 2019 In Prevention, Science

Article after article describes the ‘skyrocketing’ increases in melanoma among young women. While most are quick to point out the clear association between intentional tanning and skin cancer, few ever hint that there may be more to the story.

Read More


Doing Good in Rebecca's Name

7 February 2019 In Melanoma Stories

It was March of 2005 when Christine Garrison’s life changed forever. She received the phone call that no mother ever wants to receive. Her daughter Rebecca’s suspicious mole was, in fact, Stage 3 melanoma.

Read More


UV4Me Reaches Young Adults About Sun Safety

By Cody R. Barnett, MRA Director of Communications | 1 February 2019 In Allies & Partnerships, Prevention

Among young people, rates of melanoma are especially alarming. It is now the second most-common cancer among young women aged 20 – 29. While many programs focus specifically on children, studies suggest that we receive over half of our lifetime exposure to UV after the age of 20. Yet, few evidence-based programs focus specifically on the needs of young adults.

Read More


Unchartered Territory: When Should Patients Stop Immunotherapy?

By Cody R. Barnett, MRA Director of Communications | 23 January 2019 In Melanoma Stories, Science, Treatment

For melanoma patients, deciding when to discontinue treatment is a difficult decision. should the general ‘rule of thumb’ of treating patients with advanced disease until progression still apply? In the absence of definitive data – what does indirect data tell us?

Read More


Melanoma Treatment Advances – 2018 in Review

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 18 January 2019 In Science, Treatment

2018 brought new and expanded drug approvals that give patients, doctors, and their families more treatment options with fewer side effects. Learn more about important melanoma treatment advances in 2018.

Read More


From Health Scare to Transformative Change

By Cody R. Barnett, MRA Director of Communications | 16 January 2019 In Melanoma Stories

Debra Black founded the Melanoma Research Alliance in 2007 after her own diagnosis with Stage II disease earlier that year. Since then, MRA has become the largest, non-profit funder of melanoma research worldwide.

Read More


Estimated Rates of Melanoma Increasing in 2019

By Marc Hurlbert, Ph.D., MRA Chief Science Officer | 9 January 2019 In News, Prevention, Science

The American Cancer Society released updated estimates for the incidence, prevalence, and survival statistics for cancer in the United States. For 2019, ACS estimates that 96,480 people will be diagnosed with melanoma and that 7,230 Americans will die due to the disease. This is an increase of 5.6% and a decrease of 19% from last year respectively.

Read More


Make Your Sun Safety Habit Stick: La Roche Posay’s My Skin Track UV

By Cody R. Barnett, MRA Director of Communications | 3 January 2019 In Allies & Partnerships, Prevention

Last month’s arrival of La Roche Posay’s My Skin Track UV may be just what the doctor ordered to help people understand the danger of overexposure to ultraviolet radiation.

Read More


MRA Advisor & Grantee Dr. Allison Awarded Nobel Prize for Transforming Cancer Care

By Cody R. Barnett, MRA Director of Communications | 28 November 2018 In News, Science, Treatment

MRA Scientific Advisory Panel Member & Grantee Dr. Allison Awarded Nobel Prize for his pioneering research to harness the power of the immune system to attack cancer. His work in immunotherapy, which began in the 1990’s, was audacious at the time. It helped to mainstream an entirely new class of tools in the arsenal against cancer; joining the likes of chemotherapy, radiation, and surgery.

Read More


Dr. Marc Hurlbert Joins MRA as Chief Science Officer

By Cody R. Barnett, MRA Director of Communications | 20 November 2018 In Science

Dr. Marc Hurlbert has built his career advancing medical research in support of patients. Now, as of this month, he will translate his skills, relationships, and enthusiasm to achieving our mission of ending death and suffering due to melanoma as MRA’s Chief Science Officer.

Read More


Login

×